Praxis Precision Medicines, Inc.
PRAX
$48.09
-$0.69-1.42%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | 1,349.13% | -35.47% | -54.29% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | 1,349.13% | -35.47% | -54.29% |
| Cost of Revenue | 131.13% | 125.34% | 206.11% | 142.65% | 6.43% |
| Gross Profit | -134.20% | -129.00% | -173.18% | -147.61% | -8.34% |
| SG&A Expenses | 23.39% | -9.20% | 52.33% | 74.87% | 4.52% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 101.00% | 76.59% | 152.18% | 119.89% | 5.89% |
| Operating Income | -102.91% | -78.41% | -130.01% | -122.74% | -7.23% |
| Income Before Tax | -117.67% | -75.20% | -118.32% | -110.74% | 4.77% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -117.67% | -75.20% | -118.32% | -110.74% | 4.77% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -117.67% | -75.20% | -118.32% | -110.74% | 4.77% |
| EBIT | -102.91% | -78.41% | -130.01% | -122.74% | -7.23% |
| EBITDA | -103.37% | -78.77% | -130.76% | -123.34% | -7.25% |
| EPS Basic | -90.80% | -15.70% | 0.99% | -0.87% | 76.48% |
| Normalized Basic EPS | -90.81% | -17.49% | -1.35% | -0.87% | 76.48% |
| EPS Diluted | -90.80% | -15.70% | 0.99% | -0.87% | 76.48% |
| Normalized Diluted EPS | -90.81% | -17.49% | -1.35% | -0.87% | 76.48% |
| Average Basic Shares Outstanding | 14.08% | 51.43% | 120.51% | 108.91% | 304.88% |
| Average Diluted Shares Outstanding | 14.08% | 51.43% | 120.51% | 108.91% | 304.88% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |